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Abstract
Signal transducers and activators of transcription (STATs) are critical components of cytokine signaling pathways. STAT5A
and STAT5B (STAT5), the most promiscuous members of this family, are highly expressed in specific populations of
hypothalamic neurons in regions known to mediate the actions of cytokines in the regulation of energy balance. To test the
hypothesis that STAT5 signaling is essential to energy homeostasis, we used Cre-mediated recombination to delete the
Stat5 locus in the CNS. Mutant males and females developed severe obesity with hyperphagia, impaired thermal regulation
in response to cold, hyperleptinemia and insulin resistance. Furthermore, central administration of GM-CSF mediated the
nuclear accumulation of STAT5 in hypothalamic neurons and reduced food intake in control but not in mutant mice. These
results demonstrate that STAT5 mediates energy homeostasis in response to endogenous cytokines such as GM-CSF.
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Introduction
The central nervous system modulates feeding and energy
expenditure to maintain energy balance and metabolism within a
precise homeostatic window. Many of the neural circuits that
underlie this regulation lie within the hypothalamus, where
basomedial ‘‘satiety’’ centers, including the arcuate nucleus (Arc),
relay homeostatic information to regions that regulate satiety and
energy expenditure, such as the paraventricular hypothalamic
nucleus (PVN) and brainstem [1]. The lateral hypothalamic area
(LHA) conversely mediates a variety of appetite-promoting signals.
Cytokines mediate many of the physiologic cues that activate
neuronal signaling in these regions to regulate energy balance.
Notably, ciliary neurotrophic factor (CNTF), the adipocytokine
leptin, and granulocyte-macrophage colony-stimulating factor (GM-
CSF) and IL-6 regulate food intake and body weight via the
activation of endogenous hypothalamic cytokine receptors that
mediatesignalingviatheJanuskinase2(JAK2)andsignaltransducer
and activator of transcription (STAT) pathways. Mouse genetics has
demonstrated that STAT3 [2,3,4,5] is essential for the regulation of
energybalanceinresponsetoleptinandotherendogenouscytokines.
Similarly, neural SOCS3, an inhibitor of JAK2 and a variety of
STATs, blocks signaling by several cytokines and thereby increases
feeding and body weight by attenuating cytokine signaling in the
CNS [6]. Reducing leptin signaling stimulates food intake and
weight gain [7]. Like leptin, central administration of the
proinflammatory cytokine GM-CSF suppresses food intake and
GM-CSF
2/2 mice are heavier and more obese than control mice
[8]. Unlike leptin and CNTF, which activate STAT3 more robustly
than STAT5A/B (STAT5), GM-CSF preferentially activates
STAT5. Indeed, GM-CSF-dependent proliferation of macrophages
is dependent on the presence of STAT5A [9].
STAT5 is expressed in distinct neuronal populations in the Arc
[10,11,12], including dopaminergic [12] and somatostatin neurons
[13]. Based on the knowledge that STAT5 and the GM-CSF
receptor are present in hypothalamic neurons, we asked whether
STAT5 contributes to the regulation of energy homeostasis and
whether the action of GM-CSF on the regulation of energy
balance depends on its ability to increase STAT5 activity in the
CNS. This hypothesis was tested through the deletion of the Stat5
locus using the Nestin-Cre transgene, which is active throughout the
CNS and the pituitary gland [14,15]. Here we present the effect of
loss of STAT5 in neurons and establish a connection between
GM-CSF and STAT5 in controlling energy homeostasis.
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STAT5 expression in hypothalamic neurons and neuronal
deletion of STAT5A/B
Immunohistochemical analysis using antisera reactive with both
STAT5 isoforms demonstrated the prominent presence of STAT5
in discrete neuronal populations in a number of areas in the adult
brain including basal ganglia, septum, cortex (not shown) and
hypothalamus (Figure 1A). Particularly relevant to the phenotype
described in this study, we detected STAT5 in a limited number of
cells within areas of the hypothalamus known to regulate feeding
and energy balance (Figure 1A), including the Arc, dorsomedial
and ventromedial hypothalamic nuclei (DMH and VMH), and the
LHA, suggesting a potential role for Stat5 in energy homeostasis.
Since Stat5
-/- mice die perinatally [16], we used Cre-mediated
recombination to delete the Stat5 locus throughout the brain,
Figure 1. Reduced STAT5 expression in hypothalamic neurons in Stat5
fl/fl; Nestin-Cre male mice. (A) Immunohistochemical analyses with
aSTAT5 antibodies were performed on hypothalamic tissues from Stat5
fl/fl control (ff, left panels) and Stat5
fl/fl; Nestin-Cre (ffnc, right panels) mice. Note
the prominent expression of STAT5 isoforms in discrete neurons and the dramatic reduction in STAT5-positive cells in ffnc mice. Upper panels show
hypothalamic sections rostral to those shown in lower panels. 3V=third cerebral ventricle, ME=median eminence, f=fornix; all other abbreviations
as defined in the text. (B) Immunostaining for STAT5 (green, top), the neural marker, Hu (red, middle) and merged images (bottom) in the LHA ff and
ffnc animals. This demonstrates the co-localization/expression of STAT5 in neurons of ff animals and the absence of STAT5 from many Hu-positive
neurons in ffnc mice. (C) Total RNA from microdissected hypothalamic subregions of ff and ffnc mice was subjected to semi-quantitative real-time
PCR for STAT5A and STAT5B mRNA expression, confirming the reduction in the expression of both STAT5 isoforms in each region.
doi:10.1371/journal.pone.0001639.g001
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fl/fl locus (in
which the genes encoding STAT5A and STAT5B are flanked by
loxP sites) [16] were bred with Nestin-Cre transgenic mice [14,15]
to produce Stat5
fl/fl; Nestin-Cre mice and Stat5
fl/fl controls. Immuno-
fluorescent examination of STAT5 expression in the hypothala-
mus of these animals demonstrated overall decreased STAT5
immunoreactivity and the loss of detectable STAT5 protein from
the majority of neurons in the hypothalamus (Figure 1A and 1B).
Immunofluorescent staining for STAT5 and the neuron-specific
marker Hu [17] revealed the extensive co-localization of STAT5
and Hu in control mice and the absence of STAT5 from most Hu-
expressing neurons in Stat5
fl/fl; Nestin-Cre mice (Figure 1B). We
additionally assessed the loss of STAT5 isoforms from hypotha-
lamic nuclei known to be central to the regulation of energy
balance by semi-quantitative RT-PCR analysis of STAT5A and
STAT5B mRNA from microdissected Arc, PVN, and LHA tissues
of control and Stat5
fl/fl; Nestin-Cre mice (Figure 1C). This analysis
revealed the approximately 50–80% reduction in STAT5A
mRNA and 75–90% reduction in STAT5B mRNA in all areas
examined, with the most prominent reduction in the LHA
(Figure 1C). These data are consistent with efficient excision of
the Stat5 locus from regions of the hypothalamus that regulate
energy balance in the Stat5
fl/fl; Nestin-Cre mice.
Neuronal deletion of the Stat5 locus results in obesity
Metabolic parameters and body weight of Stat5
fl/fl; Nestin-Cre mice
were monitored from 8 to 22 weeks of age. Both male and female
mutant mice gained significantly more weight than control litter
mates (Figure 2). Although 8 week-old mutant females were
already significantly heavier than controls, differences in weight
were more profound after 16 weeks of age. While the weight of
control female mice increased only 10% between 12 and
22 weeks, mutants almost doubled their weight during this time
interval (Figure 2B). By 26 weeks of age, Stat5
fl/fl; Nestin-Cre mice
weighed on the average 65% (males) and 60% (females) more
than their control litter mates. The total amount of fat in
Stat5
fl/fl; Nestin-Cre male and female mice increased 2.5- and 3.5-fold,
respectively (Figure 3A, left panel). Notably, the lean mass of
mutant male and female mice increased by 40% and 20%,
respectively (Figure 3B). Total body fat (expressed as percentage of
Figure 2. Increased body weight of Stat5
fl/fl; Nestin-Cre mice. Body weight curves of males (A, Stat5
fl/fl, n=14; Stat5
fl/fl; Nestin-Cre, n=8) and females
(B, Stat5
fl/fl, n=5; Stat5
fl/fl; Nestin-Cre n=6). Two Way Repeated Measured ANOVA test revealed that the effect of the genotype on body weight was
significant in males (F(1,103)=5.77, P=0.024) and females (F9(1,36)=64.6, P,0.001) (B). Panels C and D show body weights at various ages combined
from several cohorts of mice. Values are mean6SEM, n=5–37 per group. Two Way ANOVA analysis of variance for each age group shows a significant
effect of genotype on body weight at all ages tested: 8 weeks2F(1,70)=4.5, P=0.037; 10 weeks2F(1,89)=24.3, P,0.001; 12 weeks2F(1,99)=6.4,
P=0.013; 14 weeks2F(1,80)=8.98, P=0.004; 16 weeks2F(1,87)=14.9; P,0.001; 18 weeks2F(1,22)=56.1, P,0.001; 20 weeks2F(1,13)=37.1,
P,0.001; 22 weeks2F(1,20)=18.6, P,0.001. The effect of gender on body weight was significant at weeks 8 through 16 (with F values ranging
from 24 to 87, P,0.001). The interaction between genotype and gender was detected at week 10 only (F(1,89)=11,2, P=0.01).
doi:10.1371/journal.pone.0001639.g002
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fl/fl; Nestin-Cre mice was 150%
and 200%, respectively of that measured in control mice
(Figure 3A, right panel). Body size, as measured by snout-anus
length, of mutant and control mice was similar (Figure 3C).
At 22 weeks of age, both subcutaneous (Figure 4A) and visceral
(Figure 4B) fat mass were increased in Stat5
fl/fl;Nestin-Cre mice
compared to Stat5
fl/fl control mice. Individual fat pads from control
and mutant female mice were dissected and weighed to evaluate the
distribution of fat mass. The weight of all 5 fat pads (inguinal,
parametrial, retroperitoneal, mesenteric and perirenal) in mutant
mice was at least doubled in mutant compared to control animals
(Figure 4C). To determine whether increased adipose tissue mass
was the result of an increased size of individual adipocytes, increased
cell number or a combination of both, cell sizes were measured
from paraffin embedded sections. In inguinal, parametrial and
mesenteric fat pads, the mean cross-sectional areas of adipocytes in
Stat5
fl/fl; Nestin-Cre mice were significantly larger than this in Stat5
fl/fl
mice (Figure 4D–F), suggesting increased lipid storage contributes to
the increased fat mass in these animals.
STAT5 mutant mice have elevated leptin levels and
display insulin resistance
Serum analysis of fed mice demonstrated elevated levels of TG,
FFA, insulin and leptin in 22 week-old mice Stat5
fl/fl; Nestin-Cre mice
Figure 3. Increased body fat in Stat5
fl/fl; Nestin-Cre mice. (A) Fat mass of 22 week-old males (n=4/group) and females (n=5/group). Left panel
shows the amount of fat in grams. By Two Way ANOVA followed by Holm-Sidak test the effect of genotype was significant ( F(1,14)=83.1, P,0.001).
Right panel represents fat mass as a percentage of body weight (F(1,14)=42.4, P,0.001 for the effect of genotype; F(1,14)=8.0, P=0.014 for the
gender effect. (B) Lean mass of 22 week-old males and females in grams (left panel-( F(1,14)=137, P,0.001 for the genotype effect; F(1,14)=164,
P,0.001 for the gender effect). Right panel presents lean mass as a percentage of total body weight (F(1,14)=70.4, P,0.001, for the genotype effect,
F(1,14)=30.7 for the gender effect). Body weights were: Stat5
fl/fl males 30.561.5, Stat5
fl/fl; Nestin-Cre males–49.860.9 g; Stat5
fl/fl females 25.361.3 g,
Stat5
fl/fl; Nestin-Cre females–39.461.5 g; F(1.14)=143, P,0.001 for the genotype effect, F(1,14)+30 for the gender effect. (C) X-ray images of
Stat5
fl/fl; Nestin-Cre and Stat5
fl/fl control male mice (right panel) showing similar size of bone length. There was no statistically significant difference in
body length as shown in the graph (left panel).
doi:10.1371/journal.pone.0001639.g003
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approximately 8-fold and 4.5-fold, respectively. Consistent
with the increase in circulating insulin, Stat5
fl/fl; Nestin-Cre mice
were glucose intolerant and insulin resistant (Figure 5). Thus,
similar to many other mouse models of obesity, Stat5
fl/fl; Nestin-Cre
mice demonstrated some features of metabolic syndrome,
including hyperlipidemia, hyperinsulinemia, insulin resistance
and glucose intolerance. With the caveat that GH secretion in
rodents is pulsatile, single measurements of GH levels suggests no
differences between control and mutant mice. Normal IGF-1
levels (Table 1) and body lengths (Figure 3C) further argue for
normal GH levels.
STAT5 mutant mice have elevated food intake
To determine whether the increased body weight was associated
with increased food consumption, we measured daily food intake
every 4 weeks between the ages of 8 and 16 weeks. This analysis
detected increased food intake in male but not in female
Stat5
fl/fl; Nestin-Cre mice during this period (Figure 6). At the age of
26 weeks both mutant males and females ate significantly more
than controls per animal. When the data were normalized to lean
mass, the difference remained significant in females (Table 2). To
test whether changes in energy expenditure could also contribute
to obesity in Stat5
fl/fl; Nestin-Cre mice, we measured oxygen
consumption and activity. At the age of 12 weeks oxygen
Figure 4. Analysis of fat depots and adipocyte size fat analysis from 22 week-old female mice. Subcutaneous (A) and visceral (B) fat
were increased in Stat5
fl/fl; Nestin-Cre mice, compared to Stat5
fl/fl control mice. (C) Unpaired t-test was used for comparison of fat pad weights from
Stat5
fl/fl; Nestin-Cre and Stat5
fl/fl control mice. Ing (inguinal, t(8)=5.6, P,0.001), ParaM (parametrial, t(8)=4.1, P=0.004), Retro (retroperitoneal, t(8)=2.9,
P=0.019), Mes (mesenteric, t(8)=5.3, P,0.001)) and P-renal (perirenal, t(8)=3.2, P,0.013). See figure 3 for body composition and body weight data.
(D–E) Images of cross-sectional adipocytes from Stat5
fl/fl (D) and Stat5
fl/fl; Nestin-Cre mice (E). (F) Comparison of cell size distribution between two
different genotypes for each fat pad. Values are mean cross-sectional area of each fat pad6SEM (n=3–5 mice per group). Cross-sectional areas
less than 100 mm
2 were considered artifacts generated during image processing and were not used for statistical analysis. Adipocytes from
Stat5
fl/fl; Nestin-Cr mice were significantly larger in inguinal fat (t(8)=5.3, p,0.001), parametrial fat (t(8)=2.8, p=0.02) and mesenteric fat (t(6)=3.1, 0.02).
doi:10.1371/journal.pone.0001639.g004
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not shown). At 26 weeks of age, male Stat5
fl/fl; Nestin-Cre were 60%
heavier and were consuming more oxygen per mouse (Table 2).
Oxygen consumption normalized to lean mass was significantly
reduced in male Stat5
fl/fl; Nestin-Cre compared to the control mice,
but not in female mice (Table 2). In contrast, there was no
difference in total activity, suggesting that changes in energy
expenditure in males are likely attributable to reduced basal
metabolic rates. Since increased food intake in males was observed
prior to changes in energy expenditure, the data suggest that
hyperphagia might be the primary cause of obesity in both male
and female mice.
STAT5-mutant mice have reduced cold tolerance
The CNS pathways that regulate food intake and energy
balance overlap at many points with the systems that regulate
body temperature. For example, STAT3 and cytokines such as
leptin each contribute to regulate energy balance and the ability to
maintain body temperature [3,18]. We thus examined whether
neuronal STAT5 similarly contributes to cold tolerance.
Stat5
fl/fl; Nestin-Cre and control female mice had body weights of
36.2 g and 25.6g, respectively. Mutant and control males had
body weights of 50.3 g and 31.8 g, respectively. 26 week-old mice
were housed at 4uC for 6 hours and body temperatures were
measured every hour. While the body temperature of littermate
controls dropped ,0.7uC over the 6 hour period, the body
temperature of mutant males decreased by ,1.4uC (Figure 7A)
and that of females by 2.0uC (Figure 7B). These data establish that
neuronal STAT5 contributes to the regulation of body temper-
ature, as well as to the control of food intake and body adiposity.
Arcuate nucleus gene expression in STAT5-mutant mice
In order to determine the potential dysregulation of Arc gene
expression in Stat5
fl/fl; Nestin-Cre mice, we microdissected the Arc of
control and Stat5
fl/fl; Nestin-Cre animals and analyzed the expression
of the neuropeptides POMC, AgRP, and NPY, and the
obesogenic JAK/STAT inhibitor SOCS3 by semi-quantitative
qPCR (Figure 8). This analysis demonstrated no significant
difference in neuropeptide gene expression in the Arc of
Stat5
fl/fl; Nestin-Cre animals but revealed decreased SOCS3 mRNA
expression in the Stat5
fl/fl; Nestin-Cre mice. This reduction in Arc
SOCS3 mRNA expression in the STAT5 mutant mice is
consistent with results from other tissues in which deletion of
STAT5 reduces the baseline expression of SOCS3 [19], and
demonstrates the importance of STAT5 in the regulation of Socs3
gene expression in the hypothalamus as well as peripheral tissues.
Thesedatafurthermoresuggestthattheregulationofenergybalance
by CNS STAT5-mediated transcriptional control is mediated by
mRNAs other than those encoded by these Arc genes.
STAT5 mediates GM-CSF actions in the CNS
Central administration of GM-CSF to rats and mice decreases
food intake and body weight [8]. Since STAT5 signaling is central
to GM-CSF action [9], we hypothesized that diminished GM-CSF
action in the CNS may contribute to the obesity of Stat5
fl/fl; Nestin-Cre
animals. While the antibodies against phosphorylated STAT5 that
we tested functioned poorly for immunohistochemistry in brain
tissue, immunofluorescent detection of total STAT5 protein was
robust and revealed the depletion of diffuse STAT5 staining and
the increased intensity of STAT5 nuclear staining in the
Figure 5. Glucose and insulin tolerance tests in 22 week-old
Stat5
fl/fl and Stat5
fl/fl; Nestin-Cre mice. (A) Glucose tolerance tests were
performed on fasted 22 week-old female mice after an i.p. injection of
2 g/kg BW glucose. Results are expressed as average blood glucose
level6SEM of 5 females of each group. The effect of genotype was
significant (Two Way Repeated Measured ANOVA with Holm-Sidak test:
(F(1,24)=6.6, p=0.033. (B) Insulin tolerance test on 22 week-old
females. Mice were fasted for 9 hours followed by the administration
of 0.75U insulin per kg body weight. Results are expressed as average
blood glucose level6SEM of 5 females of each group. The effect of
genotype was significant (Two Way Repeated Measured ANOVA Holm-
Sidak test: (F(1,24)=7.3, p=0.022). GTT and ITT were perform on the
same set of Stat5
fl/f and Stat5
fl/fl; Nestin-Cre mice weighing mice 27.163.8
and 41.564.2 g, respectively.
doi:10.1371/journal.pone.0001639.g005
Table 1. Metabolic parameters in serum
Stat5
fl/fl Stat5
fl/fl;Nestin-Cre t-test
TG (mg/dl) 63682 0 0 663 t(8)=2.1, p=0.06
FFA (mM) 0.24960.008 0.40160.014 t(8)=9.2, p,0.001
Insulin (ng/ml) 0.760.06 5.7861.27 t(8)=4.0, p=0.004
Glucose (mg/dl) 181641 8 5 610 ns
Leptin (ng/ml) 19.5364.34 89.66616.57 t(8)=4.1, p=0.003
IGF (ng/ml) 287.75620 264.25612.8 ns
Adiponectin mg/ml) 21.1663.9 16.5762.5 ns
GH (ng/ml) 9.2560.85 9.2560.25 ns
Blood was collected from the tail vein directly into non-EDTA-coated capillary
tubes and centrifuged to separate the serum, which was used for assay. Values
shown are the mean6SEM; four to five 5-months-old fed female mice were
used for analysis. ns, not significant.
doi:10.1371/journal.pone.0001639.t001
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consistent with GM-CSF-dependent activation and nuclear
accumulation of STAT5 isoforms in the hypothalamus
(Figure 9A). Indeed, counting of STAT5-immunoreactive nuclei in
confocal images of these stained sections of rat brains revealed that
i3vt GM-CSF administration doubled immunohistochemically-
detectable STAT5 nuclear accumulation from approximately 20%
to 40% of LHA neurons (Figure 9B). Thus, GM-CSF increases
STAT5 nuclear accumulation in specific hypothalamic neurons, as
in peripheral target tissues [20]. In order to determine a potential
role for STAT5 in the anorexigenic actions of GM-CSF, we
examined the response of control and Stat5
fl/fl; Nestin-Cre mice to i3vt
GM-CSF (Figure 9C). While i3vt administration of 1 mgo fm o u s e
GM-CSF resulted in a significant reduction of food intake as early as
Figure 6. Food intake of Stat5
fl/fl and Stat5
fl/fl; Nestin-Cre mice was measured in a set of male mice (n=6 per group) at the age of
8-weeks (A) and 16 weeks (B). Data show the total grams of food consumed per mouse per day. Mice were housed individually for all
measurements. Values are mean6SEM. At 8 weeks of age, Stat5
fl/f weighed 25.663.1 g and Stat5
fl/fl; Nestin-Cre was 23.9+3.2 g; at 16 weeks body
weights were 28.163.3 vs 29.263.7 respectively. By Two Way Repeated Measured ANOVA there were no effect of genotype on body weight in this
cohort of male mice, however the effect of genotype on food intake was significantly different (F(1,10)=5.7, p=0.038. All pairwise multiple
comparison (Holm-Sidak test) revealed that food intake was significantly different between two groups at 16 weeks of age (P=0.0.005, t=3.2), but
not at 8 weeks of age.
doi:10.1371/journal.pone.0001639.g006
Table 2. Metabolic parameters of Stat5
fl/fl and Stat5
fl/fl;
Nestin-Cre mice
Males Females Effect of strain Effect of gender Interaction
Stat5
fl/lf
Stat5
fl/fl;
Nestin-Cre Stat5
fl/lf
Stat5
fl/fl;
Nestin-Cre
Body weight (g) 31.161.4 50.660.6* 26.861.1 32.960.7*
F(1,12)=78.8,
P,0.001
F(1,12)=79.9,
P,0.001
F(1,12)=28.7,
P,0.001
Lean mass (g) 23.960.8 35.560.4* 19.860.4 21.460.2
F(1,12)=154.5,
P,0.001
F(1,12)=292.6,
P,0.001
F(1,12)=90.5,
P,0.001
Fat mass (g) 6.261.2 12.860.5 5.761.4 9.460.1
F(1,12)=22.2,
P,0.001 NS NS
Resting oxygen consumption (ml/mouse/h) 92.862.2 104.862.7* 80.461.5 89.263.6*
F(1,12)=14.1,
P=0.003
F(1,12)=25.9,
P,0.001 NS
Resting oxygen consumption (ml/g
0.75 LM/h) 8.660.4 7.260.3* 8.660.1 9.060.4 NS
F(1,12)=9.8,
P=0.009
F(1,12)=8.9,
P=0.011
Resting respiratory exchange ratio (VCO2/VO2) 0.9160.01 0.8660.01 0.8960.01 0.8460.02 NS NS NS
Total oxygen consumption (ml/mouse/h) 107.262.7 129.763.8* 99.262.9 105.661.6
F(1,12)=25.3,
P,0.001
F(1,12)=31.3,
P,0.001
F(1,12)=7.9,
P=0.016
Total oxygen consumption (ml/g
0.75 LM/h) 10.060.4 8.960.3* 10.560.3 10.660.1 NS
F(1,12)=15.4,
P=0.002 NS
Total respiratory exchange ratio (VCO2/VO2) 0.9160.01 0.8960.01 0.9060.01 0.8560.03*
F(1,12)=5.2,
P=0.041 NS NS
Total activity at 23 uC (beam brake/min) 191.7615.8 183.8611.3 227.5627 155.1644.2 NS NS NS
Food intake (g/mouse/day) 2.960.3 4.360.2* 2.560.2 3.360.1*
F(1,12)=28.3,
P,0.001
F(1,12)=11.5,
P=0.005 NS
Food intake (g/g
0.75 LM/day) 0.26660.025 0.29360.010 0.26360.0.017 0.33060.009*
F(1,12)=7.6,
P,0.018 NS NS
Oxygen consumption and CO2 production were measure at room temperature (23uC) at the age of 26 weeks.
Values shown are the mean6SEM; Four 6 month old fed mice were used for analysis. Statistical significance is from two-way ANOVA, followed by Holm-Sidak test
(*indicate P,0.05 for comparison of strain effect within each gender).
doi:10.1371/journal.pone.0001639.t002
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fl/fl mice, there was no suppression of food
intake inStat5
fl/fl; Nestin-Cre mice(Figure 9C; see description oftwo-way
ANOVA test). In summary, these results suggest that the effects of
GM-CSF to suppress food intake require CNS STAT5.
Role for STAT5 in the regulation of the LHA
While our prior analysis of Arc mRNA expression did not reveal
a role for STAT5 in the regulation of Arc neuropeptide gene
expression, we noticed a population of highly STAT5-immuno-
reactive neurons dorsal to the fornix in LHA of wild-type animals
(Figure 1A). Our subsequent analysis demonstrated this to be
almost exclusively STAT5B (data not shown). Since our qPCR
analysis also demonstrated the most complete reduction of STAT5
mRNA expression in the LHA, we examined the potential role for
STAT5 in the LHA (Figure 10). We initially examined the co-
localization of STAT5B in the LHA with the appetite- and
activity-regulating neuropeptide, orexin (OX) by immunofluores-
cence (Figure 10A), revealing the virtually complete overlap of
neurons demonstrating the prominent expression of STAT5B with
those containing immunoreactive OX. These data suggest the
potential importance of STAT5 in the regulation of these LHA
OX neurons, prompting us to examine the regulation of Arc
neuropeptide and Hcrt gene expression in RNA prepared from the
hypothalami of the control and Stat5
fl/fl; Nestin-Cre mice following i3vt
GM-CSF treatment (Figure 10B). This analysis confirmed our
previous finding that Arc neuropeptide mRNA expression is
normal in Stat5
fl/fl; Nestin-Cre mice, and also demonstrated the
reduced expression of OX mRNA in the hypothalamus of vehicle-
treated Stat5
fl/fl; Nestin-Cre mice compared to controls. Acute i3vt
GM-CSF treatment restored the hypothalamic expression of OX
to normal levels in Stat5
fl/fl; Nestin-Cre mice, however, suggesting that
STAT5 mediates GM-CSF-induced anorexia by OX-independent
mechanisms, and that GM-CSF can regulate OX mRNA
expression independently of STAT5. Overall, however, STAT5B
is highly expressed in LHA OX neurons and regulates baseline
OX expression, suggesting that STAT5 in LHA OX neurons may
be important for the regulation of energy balance.
Discussion
As shown in this study, deletion of STAT5 in the CNS of mice
results in increased food intake, significant obesity by 17 weeks of
age, and impairment of the anorexic response to GM-CSF
administration. While a large body of evidence has pointed
towards a key role for hypothalamic STAT3 in the regulation of
energy balance, the current results suggest an important role for
STAT5 in the regulation of feeding and body fat stores in response
to endogenous signals (summary diagram Figure 11). Specifically,
we observed a link between STAT5 and GM-CSF, which is
known to play a role in the regulation of energy balance. Loss of
STAT5 in the CNS results not only in increased food intake, but
also alters the regulation of energy expenditure, as demonstrated
by the reduced metabolic rate in males and reduced tolerance to
prolonged cold exposure.
A variety of cytokines (leptin, CNTF, GM-CSF) contribute to
the regulation of food intake and energy homeostasis by the CNS
[8,21,22,23]. The cellular/neural responses to cytokines are
Figure 7. Stat5
fl/fl; Nestin-Cre mice are defective in cold-induced
thermogenesis. 26 week-old Stat5
fl/fl and Stat5
fl/fl; Nestin-Cre males (A)
and females (B) were housed at 4uC for 6 hours and rectal temperature
was measured at 60-min intervals. The reduced cold tolerance in both
males and females was statistically significant. N=4/group. Statistical
analysis was done using ‘Two Way Repeated Measures ANOVA’
followed by the ‘Holm-Sidak test’. The effect of genotype was
significant in both females (F(1, 36)=12.4, P=0.013) and males (18.2,
P=0.005). The effect of length of cold exposure was also significant in
females (F(6,36)=9.5, P,0.001) and males (F(6,36)=6.9, P,0.001
doi:10.1371/journal.pone.0001639.g007
Figure 8. Expression of neuropeptide and regulatory genes in
the Arc of Stat5
fl/fl control (ff) and Stat5
fl/fl; Nestin-Cre (ffnc)
female mice. Total RNA prepared from microdissected Arc tissue from
ff and ffnc mice was subjected to semi-quantitative real-time PCR for
POMC, AgRP, NPY and SOCS3 mRNA expression. n=9–10; * t(17)=3.7,
p=0.002 by students t test, all other comparisons, p=NS.
doi:10.1371/journal.pone.0001639.g008
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STAT transcription factors, such as STAT3 and STAT5. While
leptin, IL-6, and CNTF heavily rely on STAT3 as their
downstream mediator, GM-CSF preferentially activates STAT5
[9]. We have now provided evidence that STAT5 is activated by
GM-CSF signaling in the CNS and that CNS STAT5 is crucial for
the anorexic actions of GM-CSF; central administration of GM-
CSF decreased energy intake in control mice but not in mice that
had lost STAT5 in the CNS.
Interestingly, however, the metabolic defects observed upon
deletion of neuronal STAT5 were larger than those observed in
GM-CSF
2/2 mice, suggesting that STAT5 may mediate the
effects of other cytokine signals beyond GM-CSF (Figure 11). In
particular, while loss of GM-CSF resulted in an approximately
15% weight gain at 22 weeks of age [8], STAT5 mutant mice
displayed a 60% weight gain. Differences were also observed in the
fat mass between the two mutant strains, and there was no sign of
the depot-specific differences in fat accumulation in the
Stat5
fl/fl; Nestin-Cre mice as were observed in GM-CSF-deficient mice
[8]. Thus, although direct comparisons of this sort between the
present study and the previously studied GM-CSF
2/2 animals
must be made with some caution due to differences in strain
background and animal facility, several lines of evidence suggest
that STAT5 may function to regulate energy balance in response
Figure 9. GM-CSF induces STAT5 activity in the hypothalamus and Stat5
fl/fl; Nestin-Cre male mice do not respond to GM-CSF-induced
reduction of food intake. (A) Rats were treated with vehicle (left panels) or GM-CSF (right panels) i3vt for 60 minutes and the presence of nuclear
STAT5 was analyzed by counting STAT5-positive (green) nuclei of Hu-positive (red) neurons following immunofluorescent analysis with aSTAT5
antibodies. Dapi staining to reveal nuclei is shown in blue. Representative images from the LHA are shown, along with percent of neurons with
nuclear STAT5 localization. (B) graph of double labeled cells; n=4; *p,0.01 vs vehicle by students t test. (C) Recombinant mouse GM-CSF was
injected into the third ventricular region of 8 week-old Stat5
fl/fl; Nestin-Cre mice and Stat5
fl/fl control littermates and food intake was measured after
4 hrs (N=16 for Stat5 ff vehicle (body weight 29.860.9) and Stat5 ff GM-CSF ((body weight 29.460.9), n=6–7 for Stat5 ff; Nestin-Cre (body weight
29.761.7) vehicle and Stat5 ff; Nestin-Cre GM-CSF(body weight 29.761.8)) . Two-way ANOVA tests followed by the ‘Holm-Sidak test’ revealed
significant effect of GM-CSF on food intake (F(1,40)=4.6, P=0.039 showed a significant reduction of food intake with control mice and no significant
reduction was observed with mutant mice. The p value for the drug effect was 0.039. Using ‘All pairwise multiple comparison procedures’ the p value
for drug effect within wild type was 0.008. No significant effect was observed in the mutant group (p 0.435).
doi:10.1371/journal.pone.0001639.g009
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activated by prolactin (Prl) [11] in ARC dopamine neurons
[10,12], and by GH in somatostatin neurons [13]. Furthermore,
while STAT3 is crucial to the leptin response, leptin activates both
STAT3 and STAT5 [24]. Similarly, while STAT3 is crucial to the
physiologic leptin response, the pan-CNS deletion of STAT3
compared to animals null only for leptin receptor (ObRb) results in
a more severe phenotype [2,3].
SincedisruptionoftheSTAT3bindingsiteontheObRbresultsin
an obesity syndrome different in numerous aspects from that of
complete ObRb deficiency [2], it is possible that STAT5 may
participate in leptin action, as well. However, mice with a deletion of
STAT5 inObRb-containing neurons using anObRb-Cre transgene
[25] did not develop obesity over a period of weeks (Figure S1),
suggesting that STAT5 controls energy balance through yet to be
identified neurons. Since OX neurons do not express ObRb (data
not shown), this finding is consistent with a potential for STAT5 in
OX neurons in the regulation of energy balance.
Since the obesity observed in STAT5-mutant mice could be the
result of altered GH or Prl levels, due to the absence of STAT5 in
a subset of hypothalamic neurons, we used the sensitive measure of
mammary gland development to gauge whether GH and Prl levels
had been elevated in Stat5 mutant mice. Elevated levels of GH
and Prl would result in a precocious development of mammary
alveoli. No significant differences were observed in mammary
alveolar development between control mice and mice from which
the Stat5 locus had been deleted using the Nestin-Cre or ObRb-
Cre transgene (Figure S2), suggesting that these mice had not
experience prolonged periods of eleveated GH and Prl levels.
STAT5 is expressed in different types of neurons and likely
responds in a cell-specific fashion to a variety of cytokines to
control many physiological responses. In a well-characterized
neural circuit in the ARC, leptin activates anorexigenic (appetite-
suppressing) neurons that express pro-opiomelanocortin (POMC)
and inhibits the orexigenic (appetite-promoting) neurons that co-
express neuropeptide Y (NPY) and Agouti-related protein (AgRP).
Figure 10. Potential role for Stat5 in OX-expressing LHA neurons in mice. (A) Histochemical sections from perfused wild-type male mice
were subjected to immunostaining for OX (green, left) and STAT5B (red, middle). Right panel shows merged images demonstrating co-localization of
prominent STAT5B expression with OX-expression in the LHA. Insets: magnified view of co-labeled neurons. F=fornix. (B) Total RNA prepared from
whole hypothalamus tissue from and Stat5
fl/f (ff) and Stat5
fl/fl; Nestin-Cre (ffnc) mice treated with vehicle (veh) or GM-CSF (GM) was subjected to semi-
quantitative real-time PCR for POMC, AgRP, NPY and OX mRNA expression. n.5; *p=0.01 versus Wt Veh, S5, Veh by ANOVA F(3, 55)=4.383 with
Fisher’s LSD test.
doi:10.1371/journal.pone.0001639.g010
Figure 11. Summary diagram of cytokine signaling pathways
controlling body weight. While leptin preferentially signals through
STAT3, GM-CSF utilizes STAT5. However, since the GM-CSF-null mice
develop milder symptoms than the STAT5-mutant mice described in
this study, we propose that some of the STAT5 signaling is induced by
leptin or yet another unknown pathway.
doi:10.1371/journal.pone.0001639.g011
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CSF and/or STAT5 in the control of energy balance remain
unknown, our analysis of ARC neuropeptide expression indicates
that STAT5 operates outside of this circuit, since the expression of
these neuropeptide mRNAs is not altered in Stat5
fl/fl; Nestin-Cre mice.
Since reduced SOCS3 expression in the Arc would tend to increase
signaling by leptin and other cytokines to promote leanness, the
regulation of hypothalamic SOCS3 expression by STAT5 is also
unlikely to underlie the obesity of the Stat5
fl/fl; Nestin-Cre mice.
The prominent expression of STAT5 in LHA OX neurons
and the dysregulation of OX expression in the hypothalamus of
Stat5
fl/fl; Nestin-Cre mice suggests that STAT5 may operate in these
neurons to regulate energy homeostasis. LHA OX neurons
promote wakefulness and activity, and alteration of their function
could underlie part of the decreased metabolism of the
Stat5
fl/fl; Nestin-Cre mice, although it is unlikely to account for the
entire phenotype of these animals. We do not propose that STAT5
or GM-CSF constitute the only regulators of LHA OX neurons,
nor do we suggest that OX is the only mediator of the metabolic
action of Stat5. Indeed, the normalization of OX expression in the
Stat5
fl/fl; Nestin-Cre mice by GM-CSF treatment suggests that
alterations in OX expression do not underlie the defects in GM-
CSF action in the Stat5
fl/fl; Nestin-Cre mice. Rather it is likely that
STAT5 controls a multitude of genes involved in food intake and
energy expenditure in the metabolically-important LHA OX
neurons and elsewhere, and that the regulation of OX by STAT5
represents a single example of this.
STAT5 is also expressed and activated by cytokines in
somatostatin neurons of the periventricular nucleus and dopamine
neurons of the arcuate nucleus [13]. While the lean mass of
Stat5
fl/fl; Nestin-Cre mice was increased, neither GH, IGF-1 nor Prl
levels were elevated in these animals, however. Therefore, the
mechanism underlying the increased lean mass in the absence of
neuronal STAT5 remains to be determined.
Consistent with the importance of cytokines in the regulation of
body energy homeostasis, and with the central role of STAT
proteins in the cellular response to cytokines, our results
demonstrate a role for neural STAT5 in the regulation of food
intake and energy utilization in response to endogenous signals.
We furthermore demonstrate that STAT5 is critical to the
anorexic response to GM-CSF, a known regulator of energy
homeostasis. This novel role for STAT5 thus defines a key player
in the CNS-mediated control of energy balance.
Methods and Materials
Generation of neuron-specific STAT5 knockout mice
Stat5
fl/fl mice [26] were bred with a mouse containing the Nestin-
Cre transgene [27]. Stat5
fl/+; Nestin-Cre mice were mated with Stat5
fl/fl
to generate Stat5
fl/fl; Nestin-Cre mice. All experiments were performed
by using progenies of Stat5
fl/fl mice crossed with Stat5
fl/fl; Nestin-Cre
mice (129xC57BL/6 background). All mice were maintained on a
12-h light, 12-h dark cycle and fed water an open formula NIH-
specified diet for maintenance, growth and reproduction (NIH-07
rodent diet; http://www.zeiglerfeed.com/ratmouse.asp). The
NIDDK Animal Care and Use Committee approved all
procedures and studies were conducted in accordance with
National Institutes of Health guidelines. Genotyping was per-
formed by PCR amplification of tail DNA from each mouse at 3
weeks of age. The primers for genotyping of the Stat5 floxed allele
were primer 1 (59-GAA AGC ATG AAA GGG TTG GAG-39),
primer 2 (59-AGC AGC AAC CAG AGG ACT AC-39) and
primer 3 (59-AAG TTA TCT CGA GTT AGT CAG G-39).
Primer pair 1 and 2 amplified a fragment of 450 bp from wild-type
mice and a 200-bp fragment was detected by primer 2 and 3; the
latter is located in the pLoxpneo vector, in mice heterozygous or
homozygous for the Stat5 floxed allele. Using PCR we also
detected Nestin-Cre-mediated recombination of the floxed Stat5
allele in the pituitary gland (data not shown).
Analysis of hypothalamic RNA
Hypothalami were isolated from age-matched mice between 10-
12 AM and snap-frozen whole or microdissected into various
subregions using a mouse brain matrix before snap-freezing. Total
RNA was isolated using Trizol reagent. For determination of
relative RNA concentration, total RNA was subjected to
automated fluorescent RT-PCR on an ABI 7700. GAPDH
control, STAT5A, STAT5B, orexin and SOCS3 primers and
probes were also supplied by ABI. POMC, AgRP and NPY
primers and probes were as previously described (1). Each
predicted RT-PCR product spanned an intron/exon junction.
Each RT-PCR reaction was determined to be in the linear range
for quantitation by comparison to serial dilutions of input RNA.
Immunofluorescent analysis of hypothalamus
Mice or rats (treated with GM-CSF or vehicle i3vt for
60 minutes, where indicated) were deeply anesthetized (90 mg/
kg sodium pentobarbital) and perfused transcardially with
formalin. Removal of the brain, post-fixation, cryoprotection,
sectioning and immunofluorescence were as described [28]. In
brief, free-floating tissue sections were blocked in donkey serum
and then incubated with primary antibody before washing,
incubation with fluorophore-conjugated secondary antibodies,
and mounting. Antibodies against total STAT5 were obtained
from Cell Signaling, Inc., antibodies against STAT5B were from
Santa Cruz, aHu was from Invitrogen, and aOX was from
Calbiochem. Images were then captured under fluorescent
microscopy with a digital camera. For quantitation of STAT5
nuclear localization, confocal images were utilized to assess co-
localization of STAT5-immunoreactivity with DAPI.
Serum analysis and glucose/insulin tolerance test
Blood glucose levels were determined from the tail vein using a
glucometer (Accu-Chek, Roche, Indianapolis, IN). Serum insulin
and leptin levels were measured by radioimmunoassay (Linco
Research Inc., St. Charles, MO). Serum FA and triglyceride levels
were analyzed in fed mice using a commercial FA kit (Roche,
Indianapolis, IN) and the GPO-Trinder kit (Sigma Chemical Co.,
St. Louis, MO), respectively. Insulin and glucose tolerance test
were performed in fasted animals after i.p. injections of either
insulin (0.75U/kg body weight) or glucose (2 g/kg body weight).
Blood glucose values were measured immediately before and 15,
30 and 60 min after insulin injection, and before and 15, 30, 60,
and 120 min after glucose injection. GH level was measured in
Harbor-UCLA Med Center (National Hormone and Peptide
Program) and IGF-1 level was measured in St. Joseph Hospital
(Bangor, ME).
Body composition
Body composition was measured in conscious mice using an
NMR analyzer (Echo MRI 3-in-1, Houston, TX).
Fat analysis
For determining the size of individual fat depots, animals were
dissected and the wet mass of four intra-abdominal depots
(parametrial, retroperitoneal, mesenteric, perirenal) and one
subcutaneous depot (inguinal) were weighed. For determining
adipocyte size, adipose tissue was immediately fixed in a 10%
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cut into 5 mm sections, mounted, and stained with hematoxylin
and eosin. Stained slides were examined with a Nikon Eclipse
E600 microscope equipped with a SPOT RT (Real Time) digital
camera at bright field and 20X magnification. Digital images were
taken for 3 non-overlapped microscope fields in each fat pad from
the same animal. The measurement of cross-sectional area of
adipocytes was determined as described previously [29]
Food intake, metabolic rate, locomotor activity, and body
temperature
Each mouse was housed individually and the amount of food
was measured at day 0 using a regular scale. Two days later, the
amount of food left in the feeding rack was measured, subtracted
from the initial weight of food and divided by 2. The same
experiment was repeated twice with the same set of mice at the
same age. Metabolic rate was measured in fed mice 6 month of
age by indirect calorimetry using the Oxymax system (Columbus
Instruments, Columbus, OH). Data were collected for 24 h at
room temperature (23uC) and for 24 h at thermoneutral
temperature (30uC). Locomotor activity (total and ambulating) was
measured using an infrared activity monitoring system (Columbus
Instruments, Columbus, OH) while the mice were in the metabolic
cages. Data are expressed as the average of 24 h and normalized to
(total body weight)
0.75. Body temperature measurements were taken
between 1 and 3 pm or at midnight using a rectal thermometer
(model TH-5; Braintree Scientific, Massachusetts).
Statistical analysis
All results are reported as mean6SEM for equivalent groups.
Statistical analyses were performed using SigmaStat software.
One-way, two-way ANOVA, Two Way Repeated Measures
ANOVA or t tests were used. Results are presented as ANOVA:
F(n,n)=XX.X, p,0.0X; t-test t(n)=XX.X, p,0.0X where n
shows the degree of freedom.
Third cerebroventricular cannulation surgery
A permanent cannula directed toward the third cerebral
ventricle was implanted in Stat5
fl/fl; Nestin-Cre and Stat5
fl/fl control
mice for central injection of GM-CSF. Mice were anesthetized by
intraperitoneal injection of avertin (0.2 ml/g). Scalp fur was
shaved and mice were placed in a stereotaxic device (Kopf
Instruments; Tajunga, CA) with lambda and bregma at the same
vertical coordinate. Coordinates for cannula placement were
0.825 mm posterior to bregma and on the midline. A small skull
window was outlined with a fine dremel bit and removed with
forceps; the sagittal sinus was displaced laterally prior to lowering a
26-gauge stainless steel cannula (Plastics One; Roanoke, VA) such
that the cannula tip was 4.8 mm below bregma. Dental acrylic was
used to secure the cannula to the skull. Cannulas were sealed with
fitted obturators from the same vendor. Cannula placement was
verified after the mice had regained presurgical body weight by
measuring food intake in response to an i3vt (intra-third
ventricular) injection of NPY. Food was removed for 2hr in the
middle of the light phase, and at the end of that interval, 1ml NPY
[5mg/1ml] was injected. Mice consuming at least 1g of chow in the
subsequent 1hr were included in the study.
GM-CSF injection
On the day of injection, recombinant mouse GM-CSF (R&D
Systems; Minneapolis, MN) was reconstituted at 1mg/ml in a vehicle
solution of 0.05% mouse albumin/saline and kept on ice until time
of injection. Mice were weighed and assigned to weight-matched
groups, and food was removed from cages at about 5 hr prior to
onset of dark. GM-CSF or vehicle was drawn up in microinjectors
and PE50 tubing (Plastics One; Roanoke, VA) fitted to Hamilton
syringes and 1ml was injected at about 4hr prior to the onset of dark.
Food hoppers wereweighed and placed incages justprior to onsetof
the dark, and food intake was measured 4 hrs later. Mice were
allowed to rest for 1 week with ad libitum chow access. The groups
were then reversed, and mice received a second i3vt injection of the
alternate treatment, with food intake and body weight monitored at
4 hrs as in the first trial. Mice consuming at least 1 g of food within
4 hrs were included in the analysis.
Supporting Information
Figure S1 Body weight of 20 week-old Stat5
fl/fl; ObRb-Cre mice and
Stat5
fl/fl littermate controls.
Found at: doi:10.1371/journal.pone.0001639.s001 (5.69 MB TIF)
Figure S2 Wholemount analysis of mammary glands from 24
week-old female mice. Ductal development and side branching are
normal in control (a), Stat5
fl/fl; Nestin-Cre, (b) and Stat5
fl/fl; ObRb-Cre (c)
mature virgins.
Found at: doi:10.1371/journal.pone.0001639.s002 (2.64 MB TIF)
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